The Food and Drug Administration is requiring a warning label for GLP-1 medications following reports of a rare condition that can cause significant vision loss.
Coverage spectrum
Read at your length
The Food and Drug Administration is requiring a warning label for GLP-1 medications following reports of a rare condition that can cause significant vision loss.
GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Rachel Pessah-Pollack joins CBS News to discuss. The eye condition, known as non-arteritic anterior ischemic optic neuropathy, has been reported with all GLP-1 drugs.
CBS News reported the story as "GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says." Just the News reported the story as "Weight loss drugs, such as Ozempic, to carry FDA warning about rare vision-loss side effects."
2 sources have covered this story, including CBS News and Just the News. The earliest reporting in the cluster landed 45 minutes ago.
How each side is reporting it
How the left is reporting it
How the wires + center are reporting it
How the right is reporting it
Where sources agree
No shared facts cached yet.
Where they diverge
No contradictions cached yet.
How it spread
Left 1Center 0Right 1No center outlets yet.
Time since the first report
Who carried it, in order
- FirstJust the NewsNov 9, 7:00 PM ET · United StatesRight
- +26hCBS NewsNov 10, 8:59 PM ET · United StatesLeft
Claim ledger
[01] VerifiedCore event reported by 2 independent outlets across the spectrum.
[02] DisputedKey facts present in mainstream desks; corroboration thin from wires.
Framings — how each side is covering it
Mainstream Liberal
1 outlet
Mainstream Conservative
1 outlet